Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Impact Biomedical Inc. (IBO) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.01M |
|
$-2.29M |
|
-- |
|
$0.01M |
|
$2.30M |
|
$-2.29M |
|
$0.01M |
|
$-2.28M |
|
$-2.28M |
|
$-2.28M |
|
$-2.28M |
|
$-2.28M |
|
$-2.28M |
|
$-2.29M |
|
$-2.00M |
|
107.79M |
|
107.79M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.38M |
|
-- |
|
$16.71M |
|
$17.09M |
|
$1.69M |
|
-- |
|
$0.69M |
|
$2.38M |
|
$14.71M |
|
$-2.00M |
|
$14.71M |
|
107.82M |
|
| Cash Flow Statement Financials | |
$-0.46M |
|
$-0.00M |
|
$0.48M |
|
$0.00M |
|
$0.02M |
|
$0.02M |
|
$1.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.22 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-32700.00% |
|
-32700.00% |
|
-- |
|
-32628.57% |
|
-32671.43% |
|
$-0.46M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-15.53% |
|
114.31% |
|
-13.37% |
|
-15.53% |
|
$0.14 |
|
$-0.00 |
|
$-0.00 |
|